Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2010

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 2, 2011, Pages 326-335

  Sicherer, Scott H ^a   Leung, Donald Y M ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

allergy; anaphylaxis; atopic dermatitis; Dermatology; drug; food; hypersensitivity disorders; insect venom; skin disease; urticaria

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; AZTREONAM; BETAMETHASONE; BUPRENORPHINE; CEPHALOSPORIN; CLAVULANIC ACID; CORTICOSTEROID; DESLORATADINE; EPITOPE; FILAGGRIN; IMIPENEM; IMMUNOGLOBULIN E; INTERLEUKIN 7; LEVOCETIRIZINE; MEROPENEM; MILK PROTEIN; OMALIZUMAB; PENICILLIN G; PIMECROLIMUS; PREBIOTIC AGENT; RECOMBINANT ALLERGEN; RITUXIMAB; STEROID; UNCLASSIFIED DRUG; VENOM; VESPID VENOM; VITAMIN D;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CHRONIC URTICARIA; CROSS REACTION; CYTOKINE PRODUCTION; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EOSINOPHILIC ESOPHAGITIS; EPIDERMIS CELL; FOOD ALLERGY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOADSORPTION; IMMUNOTHERAPY; INNATE IMMUNITY; INSECT ALLERGY; LOSS OF FUNCTION MUTATION; LYMPHOMA; MILK ALLERGY; MOLECULAR GENETICS; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PEANUT ALLERGY; PLASMACYTOID DENDRITIC CELL; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SKIN ALLERGY; T LYMPHOCYTE; URTICARIA; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 79551491497     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.11.024     Document Type: Article

References (113)

1. NIAID-Sponsored Expert Panel, J.A. Boyce, A. Assa'ad, A.W. Burks, S.M. Jones, and H.A. Sampson Guidelines for the diagnosis and management of food Allergy in the United States: report of the NIAID-sponsored Expert Panel J Allergy Clin Immunol 126 suppl 2010 S1 58
2. J.A. Boyce, A. Assa'ad, A.W. Burks, S.M. Jones, H.A. Sampson, and R.A. Wood Guidelines for the diagnosis and management of food allergy in the United States: summary J Allergy Clin Immunol 126 2010 1105 1118
3. A. Fiocchi, H.J. Schünemann, J. Brozek, P. Restani, K. Beyer, and R. Troncone DRACMA (Diagnosis and Rationale for Action Against Cow's Milk Allergy): a summary report J Allergy Clin Immunol 126 2010 1119 1128
4. S.H. Sicherer, and H.A. Sampson Food allergy J Allergy Clin Immunol 125 suppl 2010 S116 S125
5. S.H. Sicherer, A. Muñoz-Furlong, J.H. Godbold, and H.A. Sampson US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up J Allergy Clin Immunol 125 2010 1322 1326
6. M. Ben-Shoshan, D.W. Harrington, L. Soller, J. Fragapane, L. Joseph, and Y. St Pierre A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada J Allergy Clin Immunol 125 2010 1327 1335
7. L.P. Shek, E.A. Cabrera-Morales, S.E. Soh, I. Gerez, P.Z. Ng, and F.C. Yi A population-based questionnaire survey on the prevalence of peanut, tree nut, and shellfish allergy in 2 Asian populations J Allergy Clin Immunol 126 2010 324 331
8. A.H. Liu, R. Jaramillo, S.H. Sicherer, R.A. Wood, S.A. Bock, and A.W. Burks National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006 J Allergy Clin Immunol 126 2010 798 806
9. N. Nicolaou, M. Poorafshar, C. Murray, A. Simpson, H. Winell, and G. Kerry Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics J Allergy Clin Immunol 125 2010 191 197
10. S.A. Rudders, A. Banerji, M.F. Vassallo, S. Clark, and C.A. Camargo Jr. Trends in pediatric emergency department visits for food-induced anaphylaxis J Allergy Clin Immunol 126 2010 385 388
11. J.H. Savage, A.J. Kaeding, E.C. Matsui, and R.A. Wood The natural history of soy allergy J Allergy Clin Immunol 125 2010 683 686
12. M.F. Vassallo, and C.A. Camargo Jr. Potential mechanisms for the hypothesized link between sunshine, vitamin D, and food allergy in children J Allergy Clin Immunol 126 2010 217 222
13. Y. Katz, N. Rajuan, M.R. Goldberg, E. Eisenberg, E. Heyman, and A. Cohen Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy J Allergy Clin Immunol 126 2010 77 82
14. J.J. Koplin, N.J. Osborne, M. Wake, P.E. Martin, L.C. Gurrin, and M.N. Robinson Can early introduction of egg prevent egg allergy in infants? A population-based study J Allergy Clin Immunol 126 2010 807 813
15. S.H. Sicherer, R.A. Wood, D. Stablein, R. Lindblad, A.W. Burks, and A.H. Liu Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants J Allergy Clin Immunol 126 2010 1191 1197
16. C.W. DeBrosse, M.H. Collins, B.K. Buckmeier Butz, C.L. Allen, E.C. King, and A.H. Assa'ad Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999 J Allergy Clin Immunol 126 2010 112 119
17. J.P. Abonia, C. Blanchard, B.B. Butz, H.F. Rainey, M.H. Collins, and K. Stringer Involvement of mast cells in eosinophilic esophagitis J Allergy Clin Immunol 126 2010 140 149
18. S.S. Aceves, D. Chen, R.O. Newbury, R. Dohil, J.F. Bastian, and D.H. Broide Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction J Allergy Clin Immunol 126 2010 1198 1204
19. J.D. Sherrill, P.S. Gao, E.M. Stucke, C. Blanchard, M.H. Collins, and P.E. Putnam Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis J Allergy Clin Immunol 126 2010 160 165
20. J.M. Caldwell, C. Blanchard, M.H. Collins, P.E. Putnam, A. Kaul, and S.S. Aceves Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51 J Allergy Clin Immunol 125 2010 879 888
21. S.H. Sicherer, R.A. Wood, D. Stablein, A.W. Burks, A.H. Liu, and S.M. Jones Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy J Allergy Clin Immunol 125 2010 1077 1083
22. A. Ilchmann, S. Burgdorf, S. Scheurer, Z. Waibler, R. Nagai, and A. Wellner Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II J Allergy Clin Immunol 125 2010 175 183
23. M. Wang, K. Takeda, Y. Shiraishi, M. Okamoto, A. Dakhama, and A. Joetham Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway J Allergy Clin Immunol 126 2010 306 316
24. M. Bublin, M. Pfister, C. Radauer, C. Oberhuber, S. Bulley, and A.M. Dewitt Component-resolved diagnosis of kiwifruit allergy with purified natural and recombinant kiwifruit allergens J Allergy Clin Immunol 125 2010 687 694
25. A.C. Yang, L.K. Arruda, A.B. Santos, M.C. Barbosa, M.D. Chapman, and C.E. Galvao Measurement of IgE antibodies to shrimp tropomyosin is superior to skin prick testing with commercial extract and measurement of IgE to shrimp for predicting clinically relevant allergic reactions after shrimp ingestion J Allergy Clin Immunol 125 2010 872 878
26. D. Villalta, and R. Asero Is the detection of IgE to multiple Bet v 1-homologous food allergens by means of allergen microarray clinically useful? J Allergy Clin Immunol 125 2010 1158 1161
27. N.H. van Nieuwaal, W. Lasfar, Y. Meijer, P.A. Kentie, A.E. Flinterman, and S.G. Pasmans Utility of peanut-specific IgE levels in predicting the outcome of double-blind, placebo-controlled food challenges J Allergy Clin Immunol 125 2010 1391 1392
28. R.G. Hamilton, and P.B. Williams Human IgE antibody serology: a primer for the practicing North American allergist/immunologist J Allergy Clin Immunol 126 2010 33 38
29. A. Vereda, D.A. Andreae, J. Lin, W.G. Shreffler, M.D. Ibanez, and J. Cuesta-Herranz Identification of IgE sequential epitopes of lentil (Len c 1) by means of peptide microarray immunoassay J Allergy Clin Immunol 126 2010 596 601
30. R. Ayuso, S. Sanchez-Garcia, J. Lin, Z. Fu, M.D. Ibanez, and T. Carrillo Greater epitope recognition of shrimp allergens by children than by adults suggests that shrimp sensitization decreases with age J Allergy Clin Immunol 125 2010 1286 1293
31. J. Wang, J. Lin, L. Bardina, M. Goldis, A. Nowak-Wegrzyn, and W.G. Shreffler Correlation of IgE/IgG4 milk epitopes and affinity of milk-specific IgE antibodies with different phenotypes of clinical milk allergy J Allergy Clin Immunol 125 2010 695 702
32. E.M. Savilahti, V. Rantanen, J.S. Lin, S. Karinen, K.M. Saarinen, and M. Goldis Early recovery from cow's milk allergy is associated with decreasing IgE and increasing IgG4 binding to cow's milk epitopes J Allergy Clin Immunol 125 2010 1315 1321
33. H. Hochwallner, U. Schulmeister, I. Swoboda, M. Focke-Tejkl, V. Civaj, and N. Balic Visualization of clustered IgE epitopes on alpha-lactalbumin J Allergy Clin Immunol 125 2010 1279 1285
34. B. Schouten, B.C. van Esch, A.O. van Thuijl, B.R. Blokhuis, T. Groot Kormelink, and G.A. Hofman Contribution of IgE and immunoglobulin free light chain in the allergic reaction to cow's milk proteins J Allergy Clin Immunol 125 2010 1308 1314
35. L.S. Ford, S.L. Taylor, R. Pacenza, L.M. Niemann, D.M. Lambrecht, and S.H. Sicherer Food allergen advisory labeling and product contamination with egg, milk, and peanut J Allergy Clin Immunol 126 2010 384 385
36. M.P. Crotty, and S.L. Taylor Risks associated with foods having advisory milk labeling J Allergy Clin Immunol 125 2010 935 937
37. R. Gagnon, M.N. Primeau, A. Des Roches, C. Lemire, R. Kagan, and S. Carr Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine J Allergy Clin Immunol 126 2010 317 323
38. K.H. Waibel, and R. Gomez Ovalbumin content in 2009 to 2010 seasonal and H1N1 monovalent influenza vaccines J Allergy Clin Immunol 125 2010 749 751
39. J.T. Li, M.A. Rank, D.L. Squillace, and H. Kita Ovalbumin content of influenza vaccines J Allergy Clin Immunol 125 2010 1412 1414
40. J.M. Kelso Administration of influenza vaccines to patients with egg allergy J Allergy Clin Immunol 125 2010 800 802
41. J.M. Kelso Administration of influenza vaccines to egg allergy patients: update for the 2010-2011 season J Allergy Clin Immunol 125 2010 800 802
42. K. Blumchen, H. Ulbricht, U. Staden, K. Dobberstein, J. Beschorner, and L.C. de Oliveira Oral peanut immunotherapy in children with peanut anaphylaxis J Allergy Clin Immunol 126 2010 83 91
43. A. Thyagarajan, P. Varshney, S.M. Jones, S. Sicherer, R. Wood, and B.P. Vickery Peanut oral immunotherapy is not ready for clinical use J Allergy Clin Immunol 126 2010 31 32
44. C. Dupont, N. Kalach, P. Soulaines, S. Legoue-Morillon, H. Piloquet, and P.H. Benhamou Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity J Allergy Clin Immunol 125 2010 1165 1167
45. P. Pochard, B. Vickery, M.C. Berin, A. Grishin, H.A. Sampson, and M. Caplan Targeting Toll-like receptors on dendritic cells modifies the T(H)2 response to peanut allergens in vitro J Allergy Clin Immunol 126 2010 92 97
46. Y. Song, C. Qu, K. Srivastava, N. Yang, P.J. Busse, and W. Zhao Food allergy herbal formula-2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils J Allergy Clin Immunol 126 2010 1208 1217
47. P. Lieberman, R.A. Nicklas, J. Oppenheimer, S.F. Kemp, D.M. Lang, and D.I. Bernstein The diagnosis and management of anaphylaxis practice parameter: 2010 update J Allergy Clin Immunol 126 2010 477 480
48. A. Gonzalez-Perez, Z. Aponte, C.F. Vidaurre, and L.A. Rodriguez Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review J Allergy Clin Immunol 125 2010 1098 1104
49. L. Harduar-Morano, M.R. Simon, S. Watkins, and C. Blackmore Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida J Allergy Clin Immunol 126 2010 98 104
50. F.E. Simons, E.S. Edwards, E.J. Read Jr., S. Clark, and E.L. Liebelt Voluntarily reported unintentional injections from epinephrine auto-injectors J Allergy Clin Immunol 125 2010 419 423
51. F.E. Simons Anaphylaxis Allergy Clin Immunol 125 suppl 2010 S161 S181
52. I. Alvarez-Twose, D. Gonzalez de Olano, L. Sanchez-Munoz, A. Matito, M.I. Esteban-Lopez, and A. Vega Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms J Allergy Clin Immunol 125 2010 1269 1278
53. C. Akin, P. Valent, and D.D. Metcalfe Mast cell activation syndrome: Proposed diagnostic criteria J Allergy Clin Immunol 126 2010 1099 1104
54. I. Mittermann, M. Zidarn, M. Silar, Z. Markovic-Housley, W. Aberer, and P. Korosec Recombinant allergen-based IgE testing to distinguish bee and wasp allergy J Allergy Clin Immunol 125 2010 1300 1307
55. C. Jin, M. Focke, R. Leonard, R. Jarisch, F. Altmann, and W. Hemmer Reassessing the role of hyaluronidase in yellow jacket venom allergy J Allergy Clin Immunol 125 2010 184 190
56. F. Ruëff, B. Przybilla, M.B. Bilo, U. Muller, F. Scheipl, and W. Aberer Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase J Allergy Clin Immunol 126 2010 105 111
57. M. Niedoszytko, M. Bruinenberg, J. de Monchy, C. Wijmenga, M. Platteel, and E. Jassem Gene expression analysis in predicting the effectiveness of insect venom immunotherapy J Allergy Clin Immunol 125 2010 1092 1097
58. M.S. La Shell, C.W. Calabria, and J.M. Quinn Imported fire ant field reaction and immunotherapy safety characteristics: the IFACS study J Allergy Clin Immunol 125 2010 1294 1299
59. H.M. Tartibi, A.R. Majmundar, and D.A. Khan Successful use of omalizumab for prevention of fire ant anaphylaxis J Allergy Clin Immunol 126 2010 664 665
60. K. Sugita, M. Tohyama, H. Watanabe, A. Otsuka, S. Nakajima, and M. Iijima Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome J Allergy Clin Immunol 126 2010 408 410
61. J.L. Castrejon, N. Berry, S. El-Ghaiesh, B. Gerber, W.J. Pichler, and B.K. Park Stimulation of human T cells with sulfonamides and sulfonamide metabolites J Allergy Clin Immunol 125 2010 411 418
62. A. Romano, F. Gaeta, R.L. Valluzzi, C. Caruso, G. Rumi, and P.J. Bousquet IgE-mediated hypersensitivity to cephalosporins: Cross-reactivity and tolerability of penicillins, monobactams, and carbapenems J Allergy Clin Immunol 126 2010 994 999
63. M.J. Torres, A. Ariza, C. Mayorga, I. Dona, N. Blanca-Lopez, and C. Rondon Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions J Allergy Clin Immunol 125 2010 502 505
64. L. Sanchez-Morillas, P.R. Perez-Ezquerra, M. Reano-Martos, J.J. Laguna-Martinez, M.L. Sanz, and L.M. Martinez Selective allergic reactions to clavulanic acid: a report of 9 cases J Allergy Clin Immunol 126 2010 177 179
65. L.M. Stutius, I. Pessach, J. Lee, M.S. Lo, S. Levy, and P. Schram Sublingual desensitization for buprenorphine hypersensitivity J Allergy Clin Immunol 125 2010 938 939
66. D.A. Khan, and R. Solensky Drug allergy J Allergy Clin Immunol 125 suppl 2010 S126 S137
67. K.C. Barnes An update on the genetics of atopic dermatitis: scratching the surface in 2009 J Allergy Clin Immunol 125 2010 16 29
68. D.Y. Leung Our evolving understanding of the functional role of filaggrin in atopic dermatitis J Allergy Clin Immuol 124 2009 494 495
69. M.K. Oyoshi, G.F. Murphy, and R.S. Geha Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen J Allergy Clin Immunol 124 2009 485 493
70. G.M. O'Regan, P.M. Kemperman, A. Sandilands, H. Chen, L.E. Campbell, and K. Kroboth Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes J Allergy Clin Immunol 126 2010 574 580
71. M.D. Howell, B.E. Kim, P. Gao, A.V. Grant, M. Boguniewicz, and A. DeBenedetto Cytokine modulation of atopic dermatitis filaggrin skin expression J Allergy Clin Immunol 124 2009 R7 R12
72. E. Guttman-Yassky, M. Suarez-Farinas, A. Chiricozzi, K.E. Nograles, A. Shemer, and J. Fuentes-Duculan Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis J Allergy Clin Immunol 124 2009 1235 1244
73. C.J. Broccardo, S.B. Mahaffey, M. Strand, N.A. Reisdorph, and D.Y. Leung Peeling off the layers: skin taping and a novel proteomics approach to study atopic dermatitis J Allergy Clin Immunol 124 2009 1113 1115
74. C.J. Broccardo, S. Mahaffey, J. Schwarz, L. Wruck, G. David, P.M. Schlievert, N.A. Reisdorph, and D.Y.M. Leung Comparative proteomic profiling of atopic dermatitis patients based on history of eczema herpeticum infection and Staphylococcus aureus colonization J Allergy Clin Immunol 127 2011 186 193
75. M. Boguniewicz, and D.Y. Leung Recent insights into atopic dermatitis and implications for management of infectious complications J Allergy Clin Immunol 125 2010 4 13
76. P.M. Schlievert, K.L. Strandberg, Y.C. Lin, M.L. Peterson, and D.Y. Leung Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis J Allergy Clin Immunol 125 2010 39 49
77. M. Niebuhr, H. Scharonow, M. Gathmann, D. Mamerow, and T. Werfel Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis J Allergy Clin Immunol 126 2010 1176 1183
78. J.B. Travers, A. Kozman, N. Mousdicas, C. Saha, M. Landis, and M. Al-Hassani Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid J Allergy Clin Immunol 125 2010 146 152
79. E. Sonkoly, P. Janson, M.L. Majuri, T. Savinko, N. Fyhrquist, and L. Eidsmo MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4 J Allergy Clin Immunol 126 2010 581 589
80. A.T. Vu, T. Baba, X. Chen, T.A. Le, H. Kinoshita, and Y. Xie Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway J Allergy Clin Immunol 126 2010 985 993
81. N. Novak, S. Koch, J.P. Allam, and T. Bieber Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis J Allergy Clin Immunol 125 2010 50 59
82. E. Gros, C. Bussmann, T. Bieber, I. Forster, and N. Novak Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis J Allergy Clin Immunol 124 2009 753 760
83. H. Miajlovic, P.P. Fallon, A.D. Irvine, and T.J. Foster Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus J Allergy Clin Immunol 126 2010 1184 1190
84. L.A. Beck, M. Boguniewicz, T. Hata, L.C. Schneider, J. Hanifin, and R. Gallo Phenotype of atopic dermatitis subjects with a history of eczema herpeticum J Allergy Clin Immunol 124 2009 260 269
85. P.S. Gao, N.M. Rafaels, T. Hand, T. Murray, M. Boguniewicz, and T. Hata Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum J Allergy Clin Immunol 124 2009 507 513
86. P.S. Gao, N.M. Rafaels, D. Mu, T. Hand, T. Murray, and M. Boguniewicz Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum J Allergy Clin Immunol 125 2010 1403 1407
87. D.N. Grigoryev, M.D. Howell, T.N. Watkins, Y.C. Chen, C. Cheadle, and M. Boguniewicz Vaccinia virus-specific molecular signature in atopic dermatitis skin J Allergy Clin Immunol 125 2010 153 159
88. M.K. Oyoshi, R.P. Larson, S.F. Ziegler, and R.S. Geha Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression J Allergy Clin Immunol 126 2010 976 984
89. W.H. Wu, C.O. Park, S.H. Oh, H.J. Kim, Y.S. Kwon, and B.G. Bae Thymic stromal lymphopoietin-activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis J Allergy Clin Immunol 126 2010 290 299
90. N. Meyer, M. Zimmermann, S. Burgler, C. Bassin, S. Woehrl, and K. Moritz IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis J Allergy Clin Immunol 125 2010 858 865
91. K.E. Nograles, M. Suarez-Farinas, A. Shemer, J. Fuentes-Duculan, A. Chiricozzi, and I. Cardinale Atopic dermatitis keratinocytes exhibit normal T(H)17 cytokine responses J Allergy Clin Immunol 125 2010 744 746
92. K.E. Nograles, L.C. Zaba, A. Shemer, J. Fuentes-Duculan, I. Cardinale, and T. Kikuchi IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells J Allergy Clin Immunol 123 2009 1244 1252
93. L. Schneider, A. Weinberg, M. Boguniewicz, P. Taylor, H. Oettgen, and L. Heughan Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls J Allergy Clin Immunol 126 2010 1306 1307
94. L.F. Schimke, J. Sawalle-Belohradsky, J. Roesler, A. Wollenberg, A. Rack, and M. Borte Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis J Allergy Clin Immunol 126 2010 611 617
95. A.S. Peters, J. Kellberger, C. Vogelberg, H. Dressel, D. Windstetter, and G. Weinmayr Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study J Allergy Clin Immunol 126 2010 590 595
96. M. Pincus, T. Keil, M. Rucke, C. Bruenahl, K. Magdorf, and B.F. Klapp Fetal origin of atopic dermatitis J Allergy Clin Immunol 125 2010 273 275
97. J.I. Silverberg, K.B. Norowitz, E. Kleiman, N.B. Silverberg, H.G. Durkin, and R. Joks Association between varicella zoster virus infection and atopic dermatitis in early and late childhood: a case-control study J Allergy Clin Immunol 126 2010 300 305
98. J.M. Jensen, S. Pfeiffer, M. Witt, M. Brautigam, C. Neumann, and M. Weichenthal Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis J Allergy Clin Immunol 123 2009 1124 1133
99. F.M. Arellano, A. Arana, C.E. Wentworth, C. Fernandez-Vidaurre, R.G. Schlienger, and E. Conde Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom J Allergy Clin Immunol 123 2009 1111 1116
100. P. Salfeld, and M.V. Kopp Probiotics cannot be generally recommended for primary prevention of atopic dermatitis J Allergy Clin Immunol 124 2009 170 171
101. C. Grüber, M. van Stuijvenberg, F. Mosca, G. Moro, G. Chirico, and C.P. Braegger Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants J Allergy Clin Immunol 126 2010 791 797
102. M. Kasperkiewicz, E. Schmidt, Y. Frambach, C. Rose, M. Meier, and M. Nitschke Improvement of treatment-refractory atopic dermatitis by immunoadsorption: a pilot study J Allergy Clin Immunol 127 2011 267 270
103. Y. Hatano, M.Q. Man, Y. Uchida, D. Crumrine, T.M. Mauro, and K.R. Feingold Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators J Allergy Clin Immunol 125 2010 160 169
104. C. Gandhi, C. Healy, A.A. Wanderer, and H.M. Hoffman Familial atypical cold urticaria: description of a new hereditary disease J Allergy Clin Immunol 124 2009 1245 1250
105. M. Staevska, T.A. Popov, T. Kralimarkova, C. Lazarova, S. Kraeva, and D. Popova The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria J Allergy Clin Immunol 125 2010 676 682
106. F. Siebenhaar, F. Degener, T. Zuberbier, P. Martus, and M. Maurer High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study J Allergy Clin Immunol 123 2009 672 679
107. A. Kessel, and E. Toubi Low-dose cyclosporine is a good option for severe chronic urticaria J Allergy Clin Immunol 123 2009 970 971
108. K.H. Waibel, D.A. Reese, R.G. Hamilton, and R.L. Devillez Partial improvement of solar urticaria after omalizumab J Allergy Clin Immunol 125 2010 490 491
109. P.D. Arkwright Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria J Allergy Clin Immunol 123 2009 510 511
110. M. Magerl, P. Staubach, S. Altrichter, E. Ardelean, K. Krause, and M. Metz Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab J Allergy Clin Immunol 126 2010 665 666
111. W.A. Thorp, W. Goldner, J. Meza, and J.A. Poole Reduced vitamin D levels in adult subjects with chronic urticaria J Allergy Clin Immunol 126 2010 413
112. D.A. Searing, Y. Zhang, J.R. Murphy, P.J. Hauk, E. Goleva, and D.Y.M. Leung Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid usage J Allergy Clin Immunol 125 2010 995 1000
113. S.H. Sicherer, and D.Y. Leung Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2009 J Allergy Clin Immunol 125 2010 85 97